Myths and methodologies: Assessment of dynamic cerebral autoregulation by the mean flow index

Markus Harboe Olsen1, Christian Gunge Riberholt1,2, Ronan M G Berg3,4,5,6

  • 1Department of Neuroanaesthesiology, The Neuroscience Centre, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.

Experimental Physiology
|February 20, 2024
PubMed

Insights

The mean flow index (Mx) for assessing dynamic cerebral autoregulation (dCA) has methodological issues. Current evidence does not support its clinical application due to validity and reliability concerns.

Area of Science:

  • Neuroscience
  • Physiology
  • Medical Technology

Background:

  • The mean flow index (Mx) has been a standard for dynamic cerebral autoregulation (dCA) assessment for nearly 30 years.
  • Concerns exist regarding the methodological consistency, validity, and reliability of Mx in dCA evaluation.

Purpose of the Study:

  • To critically evaluate the methodological consistency, construct validity, criterion validity, and test-retest reliability of the mean flow index (Mx) for dCA assessment.
  • To determine if current evidence supports the clinical application of Mx-based measures for dCA.

Main Methods:

  • Review of existing literature on mean flow index (Mx) calculations for dCA.
  • Analysis of methodological factors influencing Mx values, including input data, pre-processing, and artifact handling.
  • Examination of studies correlating Mx with other dCA metrics, assessing discriminatory and predictive validity, and test-retest reliability.

Main Results:

  • Methodological choices significantly impact Mx values, with no single approach proving superior.
  • Previous correlations with other dCA metrics are flawed by issues like heteroscedasticity.
  • Mx demonstrates poor discriminatory validity and inconsistent prognostic performance, with generally poor test-retest reliability.

Conclusions:

  • Significant methodological inconsistencies and validity limitations challenge the use of mean flow index (Mx) for dCA assessment.
  • Current evidence does not support the clinical application of Mx-based measures for evaluating dynamic cerebral autoregulation.
  • Caution is advised regarding the continued use of Mx for dCA evaluation until methodological concerns are resolved.